WallStreetZenWallStreetZen

NASDAQ: BLSM
Blossomhill Therapeutics Inc Stock Ownership - Who owns Blossomhill Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Blossomhill Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John P. SchmidDirector2026-08-106,000$16.00
$96.00kBuy
Carl L. GordonDirector2026-08-10625,000$16.00
$10.00MBuy
Jason A. KeyesCFO2026-08-10700$16.00
$11.20kBuy
Bihua ChenDirector2026-08-10312,500$16.00
$5.00MBuy
Vincent Paul LiptakCLO2026-08-102,200$16.00
$35.20kBuy
Orbimed Advisors LLCDirector2026-08-10625,000$16.00
$10.00MBuy
Vincent Paul LiptakCLO2026-08-072,500$15.80
$39.50kBuy

1 of 1

BLSM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BLSM insiders and whales buy or sell their stock.

BLSM Shareholders

What type of owners hold Blossomhill Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yishan Li12.50%3,973,138$56.58MInsider
Jingrong Jean Cui12.50%3,973,138$56.58MInsider
Bihua Chen11.37%3,614,034$51.46MInsider
Orbimed Advisors LLC8.54%2,714,279$38.65MInsider
Carl L. Gordon8.54%2,714,279$38.65MInsider
Sundeep Agrawal1.82%578,524$8.24MInsider
Vincent Paul Liptak0.42%134,099$1.91MInsider
Sheila Gujrathi0.28%90,160$1.28MInsider
Geoffrey Raymond Oxnard0.06%17,785$253.26kInsider
John P. Schmid0.02%6,000$85.44kInsider

1 of 2

BLSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLSM0.00%56.05%Net Buying
PHAT0.09%41.16%Net SellingNet Selling
STTK0.08%14.82%Net Buying
OCS0.03%0.00%
NGNE0.08%86.45%Net SellingNet Buying
View Top Biotech Stocks

Blossomhill Therapeutics Stock Ownership FAQ

Who owns Blossomhill Therapeutics?

Blossomhill Therapeutics (NASDAQ: BLSM) is owned by 0.00% institutional shareholders, 56.05% Blossomhill Therapeutics insiders, and 43.95% retail investors. Yishan Li is the largest individual Blossomhill Therapeutics shareholder, owning 3.97M shares representing 12.50% of the company. Yishan Li's Blossomhill Therapeutics shares are currently valued at $64.05M.

If you're new to stock investing, here's how to buy Blossomhill Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.